Clinical API Development

Clinical API Development
Product Description

CARBOGEN AMCIS has a DNA in API development, stretching back over 30 years. Our API development teams are selected for their passion for science and experience in the application of phase-appropriate efforts to solve challenging chemistry issues. From taking a promising molecule from our clients' medicinal chemistry team to optimizing a late-phase API in readiness for validation and commercialization, our API development group has the skills, experience and an unmatched set of tools to meet your goals, however challenging they may be.

Read more Show less

CARBOGEN AMCIS

  • CH
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Contract Service
View company profile
Categories
more categories Show less
Sales Markets
Show more Show less

CARBOGEN AMCIS

  • CH
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Contract Service
View company profile

More Products from CARBOGEN AMCIS (4)

  • Commercialization Services

    Product Commercialization Services

    CARBOGEN AMCIS has a track record, extending over 25 years, helping our customers transition their molecules from process development through validation and ultimately into commercial status. A range of services backed up with fully integrated support functions has been developed to facilitate and smooth t...
  • Analytical Services

    Product Analytical Services

    The complete integration of analytical sciences into the process of API development is fundamentally understood at CARBOGEN AMCIS. Our scientists, technique ranges, systems (including a fully validated LIMS) and procedures facilitate a full understanding of the unique characteristics of the complex molecul...
  • Drug Products

    Product Drug Products

    CARBOGEN AMCIS has developed a comprehensive range of services for the formulation of New Molecular Entities (NMEs) and the reformulation of existing drugs. With a specialization in developing sterile and pyrogen-free parenteral formulations for preclinical and clinical trials (phases I, II and III), CARBO...
  • Highly Potent API

    Product Highly Potent API

    CARBOGEN AMCIS has state of the art facilities and controls to handle both drug substance and drug product of the highest potency and toxicity, under cGMP. Our dedicated containment facilities use a containment methodology, utilizing barrier isolation technology and Rapid Transfer Ports (RTPs), combined wi...

CARBOGEN AMCIS resources (3)

  • News CARBOGEN AMCIS acquires new property at Bubendorf site

    BUBENDORF, Switzerland (24 June, 2021) Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced the acquisition of a new property in Bubendorf.
    11 Aug 2021
  • CARBOGEN AMCIS Company Brochure

    Brochure CARBOGEN AMCIS Company Brochure

  • Customer Journey

    Video Customer Journey

    Lost in the development of your Drug Substance? Struggling to bring your new drug from bench to market? It can be a challenging way from the development of a Drug Substance to the large-scale manufacturing of a safe medicinal product through the different clinical phases. Watch the first episode “from bench to market” of our web series and learn how CARBOGEN AMCIS can support you through the various clinical phases to bring your new drug to the market.